Skip to main content
. 2019 Feb 13;13(8):963–969. doi: 10.1093/ecco-jcc/jjz041

Figure 3.

Figure 3.

Increasing vedolizumab concentration quartiles and rates of corticosteroid-free deep remission during maintenance therapy.